New hope for elderly blood cancer patients with experimental transplant prep
NCT ID NCT07441967
Summary
This study is testing a specific combination of chemotherapy drugs given before a cord blood transplant for patients aged 60-69 with blood cancers. The goal is to see if this new preparatory regimen is safe and effective at helping the transplant succeed while controlling the cancer. Researchers will closely monitor survival, cancer recurrence, and side effects like graft-versus-host disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCIES are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.